Blackhawk Growth’s MindBio Therapeutics Advances Microdosing Clinical Trial to 59 Patients
Vancouver, British Columbia – TheNewswire – November 15, 2021 – Blackhawk Growth Corp. (CNSX:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the “Corporation”…
Blackhawk Growth’s MindBio Therapeutics Completes Safety Milestone in its Phase 1 Clinical Trials
Vancouver, British Columbia – TheNewswire – November 08, 2021 – Blackhawk Growth Corp. (CNSX:BLR.CN) (OTC:BLRZF) (Frankfurt:0JJ) (the “Corporation”…
Blackhawk Growth’s SAC Pharma Continues to Expand Product Line and Services
Vancouver, British Columbia – TheNewswire – October 12, 2021 – Blackhawk Growth Corp. (CNSX:BLR.CN) (OTC:BLRZF) (Frankfurt:0JJ) (the “Company“),…
Blackhawk Growth’s MindBio Therapeutics Successfully Progressed to the Second Half of their Phase 1 Microdosing Clinical Trial
Vancouver, British Columbia – TheNewswire – October  04, 2021 – Blackhawk Growth Corp. (CNSX:BLR.CN) (OTC:BLRZF) (Frankfurt:0JJ) (the “Company”…
Blackhawk’s MindBio Therapeutics Utilizes Trip Pharma to Bring Microdosing Trials to North America
Vancouver, British Columbia – TheNewswire – September 23, 2021 – Blackhawk Growth Corp. (CNSX:BLR.CN) (OTC:BLRZF) (Frankfurt:0JJ) (the “Company”…
Blackhawk Growth’s MindBio Therapeutics Opens World Class Facility for the Pharmaceutical Industry
Vancouver, British Columbia – TheNewswire – September 13, 2021 – Blackhawk Growth Corp. (CNSX:BLR.CN) (OTC:BLRZF) (Frankfurt:0JJ) (the “Company”…